Is progression-free survival a surrogate endpoint?
Background. Progression-free survival (PFS) is a surrogate endpoint widely used for overall survival (OS) in oncology. Validation of PFS as a surrogate must be done for each indication and each intervention.
What is a good progression-free survival rate?
A percentage of 90% is better than 30%. A longer progression-free survival period shows a longer period of stability.
What is meant by progression-free survival?
Listen to pronunciation. (pruh-GREH-shun ser-VY-vul) The length of time during and after the treatment of a disease, such as cancer, that a patient lives with the disease but it does not get worse.
Is disease free survival the same as progression-free survival?
Unlike progression-free survival in the advanced cancer setting, which refers to time from treatment to disease progression (or death) in patients who already have measurable cancer in their bodies, DFS refers to time from treatment until the recurrence of disease (or death) after undergoing curative-intent treatment.
What does PFS2 mean?
PFS2 is defined as the time from randomisation (or registration, in non-randomised trials) to second objective disease progression, or death from any cause, whichever first.
What happens after 5 year survival rate?
Beyond recurrence for the original cancer, other common post-five-year survival issues include anxiety and depression, second cancers (for example, leukemia as a result of radiation) and a variety of other possible late effects from therapy.
What is Post progression survival?
Post-progression survival (PPS) was defined as the survival time following progressive disease (PD) during treatment with nivolumab. In the present study, definition of partial response, stable disease, and PD were based on the RECIST ver.
What is the difference between EFS and DFS?
EFS is used in the neoadjuvant setting to imply time from randomization to disease relapse, recurrence, progression or death (the only difference between EFS and DFS is that EFS is in the neoadjuvant setting while DFS is in the adjuvant setting) [17]. In past trials in the adjuvant setting, EFS was used to mean DFS.
What is difference between PFS and DFS?
Disease-Free Survival (DFS), also known as Relapse-Free Survival (RFS), is often used as a primary endpoint in phase III trials of adjuvant therapy. Progression-Free Survival (PFS) is used commonly as a primary endpoint in phase III trials evaluating treatment of metastatic cancer.
Is progression-free survival a useful endpoint in solid tumors?
Abstract Progression-free survival (PFS) is increasingly used as an important and even a primary endpoint in randomized cancer clinical trials in the evaluation of patients with solid tumors, because of both practical and clinical considerations.
What does progression free survival mean?
Progression-Free Survival. PFS is defined as the time from randomization to progression or death. (Time to progression is a related, less-preferred end point wherein deaths without progression are censored observations rather than counted as events.)
What is prognosis-free survival (PFS)?
Progression-free survival (PFS) is increasingly used as an important and even a primary endpoint in cancer clinical trials for patients with solid tumors.
Does progression-free survival predict survival in metastatic renal cell carcinoma?
We are unlikely to have rigorous validation of progression-free survival as a predictor for survival of patients with metastatic renal cell carcinoma, but they are a group in which positive clinical trials are a recent phenomenon, and in which there are few therapies that can influence therapy after disease progression.